Selection of ongoing and completed studies

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of neurotoxic chemotherapy drugs, particularly taxanes and platinum preparations. Pressure-adjusted compression is an innovative method for preventing and reducing CIPN. It was further developed by MEDIACC and filed for a patent. Pressure-adjusted compression using tight-fitting gloves or stockings with matching pads is a promising, easy-to-implement method for reducing CIPN. It can significantly reduce the risk of relevant nerve damage and is well tolerated by patients.

Our results on the mechanism of action have already been presented at international congresses and have received awards.

A DiGA for the treatment of back pain, based on the latest orthopedic and physiotherapy findings. Corrections are also suggested so that the exercises work well. It is scientifically tested whether the 12-week use has higher medical benefits compared to standard therapy.

MEDIACC supports the conception, planning, statistical considerations and tailor-made study design for the innovative product

Data generated with AI from everyday language - to diagnose the onset of overhydration in heart failure. The information is evaluated via telemetry in accordance with German security and data protection standards. If there are any changes, general practitioners will be informed and treatment can be adjusted at an early stage.

Once again, MEDIACC's task was to generate reliable evidence while avoiding a large-scale randomized clinical trial. This was achieved through deep knowledge of regulations and elegant scientific processes. We wish the start-up every success in this very relevant indication!

People who lie motionless for a long time benefit from regular rearrangements. However, this can lead to sleep disorders, especially at night, with proven restrictions during the day. Data had to be generated so that the innovative product could be included in the tool directory. We in MEDIACC were able to prevent a complex multicenter RCT by entering into a detailed and scientifically based discussion with the National Association of Statutory Health Insurance Funds. The result? The cost-intensive study could be avoided and the product was included in the list of aids! Congratulations!

The clinical study to further develop an innovative technology for skin cancer diagnostics, in particular for malignant melanoma, is testing the new optimized algorithm for intelligent measurements.

The study is being carried out in close collaboration with a renowned and university dermatology clinic and uses cutting-edge digital dermatoscopy and artificial intelligence to support medical professionals. The results should help to further improve the early detection and diagnosis of skin cancer and set new standards in dermatological diagnostics.

‍

Image generated using AI (ChatGPT/DALL·E)

What most products promise should be scientifically based and proven beyond doubt, generating all data for certification as a medical device. In a randomised, group-controlled, open, multicentre study, weight loss in obesity was proven by changing eating habits. All people were allowed to eat whatever they wanted in the desired quantity. Congratulations to the inventor on this success!

‍

Metabolomic changes occur as a result of interactions between genetics, environmental factors (diet, toxins) and our intestinal microbiome. Different signatures are found in metabolic diseases (diabetes, obesity), cancers, neurological diseases (epilepsy, depression, neurodegenerative), immunological diseases and cardiovascular diseases. Designing a meaningful, scientifically based and affordable clinical trial is a challenge that we were happy to accept.

In order for children and adolescents to participate in life, they need dynamic orthotics that support their physiotherapists and facilitate lifelong treatment. Only those who can open their hand can play the ball back. We are pleased about the university cooperation with the SPZ, which has only led to the reimbursement of a new medical aid by the National Association of Statutory Health Insurance Funds!

The aim of an innovative digital application is to provide men with comprehensive advice, to identify the causes of their erectile dysfunction and to develop individual solutions together with them for a fulfilling sex life. For this purpose, a hybrid scientific investigation is carried out from a specialized practice.

In university neonatology, people decide on the future of the protected premature babies; it sometimes and again comes down to seconds. We support colleagues in their ideas to become even better with medical devices. We are impressed by the excellent ideas!

Relief of acute or chronic orthopedic pain through the local use of cooling and mild negative pressure. The retrospective systematic analysis of application monitoring and systematic survey of operators on the impact and safety of an innovative medical device is being created here.

Put new treatment options in pain medicine to the test for many people in an easy and scientifically validated app. That is the aim of this nationwide scientific investigation.

It is a certified medical device. The study is being carried out completely digitally throughout Germany.

Relieve snoring with an app and exercises - available soon with more information

This nationwide scientific study aims to verify the effectiveness of digital therapy for treating severe obesity (Digital Health Application — DiGA) and to investigate the impact on the quality of life.

It is a certified medical device. The study is being carried out completely digitally throughout Germany. The study has been extended.

Multiple international prospective, randomised, and blinded trials, alongside a registry study, are evaluating whether a three-dimensional electrocardiogram with subsequent AI-powered analysis can determine an individual's risk of coronary ischaemia. The device in question is classified as a medical product.

The NHS is sponsoring a major field study in the United Kingdom. Participants are enrolled through their doctors, with subsequent monitoring conducted either in-person or via digital means, as clinically warranted.

This nationwide scientific study aims to test the effectiveness of a digital health application (DiGA) for quitting smoking. It is a medical device that provides scientifically based elements for quitting smoking.

The app contains elements that can increase motivation to stop smoking and make it easier to successfully deal with smoking cravings. The study is carried out completely digitally.

As part of this nationwide scientific investigation, it is intended to test whether rehabilitation after surgical treatment of a knee joint injury with a digital application in addition to sole physiotherapy is better than physical therapy alone (current standard of care).

The digital application is a medical device that enhances knee rehabilitation through a combination of tests, a training program and a knowledge database. The app consists of a motion sensor and an app and enables a supplementary, independent and flexible continuation of knee joint rehabilitation from home. The registration is carried out by doctors, after which the follow-up is digital.

This multicenter, prospective, group-controlled study for early cancer detection is intended to verify whether a new blood test is suitable for distinguishing malignant tumours (cancers) from other tumories/diseases and control subjects.

The AFORCE-1 study aims to test the accuracy of this blood test before it can later be used in diagnostics. This includes patients with suspected tumours (10 most common types of tumours) and healthy volunteers. The development of suspected tumours is observed over a period of 12 months and compared with the results of the blood test for early cancer detection at the end of the study.

The study was rated positively on 05.04.2024 by the Colorectal Cancer Study Board of the German Cancer Society. It therefore meets the criteria for recognition of the study within the certification system and is included in studybox (www.studybox.de) listed. The registration number is: ST-U178.